Kaplan-Meier survival curves of 260 myeloma patients included in the HOVON-50 study by donor availability. Actuarial rates of PFS (A) and OS (B) according to availability of an HLA-identical sibling, that is, donor versus no-donor. PFS and OS are presented as from the date of autologous SCT.